ecancermedicalscience

Short Communication

Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia

17 Jul 2020
Saleh A Alessy, Elizabeth A Davies, Abdul-Rahman Jazieh

The coronavirus disease 2019 (COVID-19) pandemic continues to disrupt many healthcare settings worldwide including cancer care. COVID-19 has been associated with worse outcomes amongst cancer patients. Saudi Arabia has experienced several Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks that affected the continuity of cancer care. In this paper, we describe how Saudi Arabia responded to COVID-19, how cancer care was re-restructured during this pandemic and how the recent MERS-CoV experience may have improved the Saudi response to COVID-19.

Related Articles

Adnan-Mustafiz Chowdhury, Sattam A Halaseh, Debora Joseph, Abel I Abel, Nikita Jha, Amro Al-Karadsheh, Hakam Al-Karadsheh, Omar A Salem, Sama F Salaitah, Noor M Arman, Georges Rizkallah
Koreddi A Dora, Vaka Rajashekhar, Mahadevapura R Kaushik, Gaurav Vora, Arti Sarin, Amol Patel
Kevin Guzmán, Vanessa Pabón, Andrés Angulo, Luis E Bravo, Arsenio Hidalgo, Carol Rosero, Alvaro Pazos
Rachael O Oduyemi, Chizoma Millicent Ndikom, Gloria Oluwakorede Alao, Iyanuoluwa O Ojo, Faith Ayomide Ajayi, Damilola Ajibade, Abdullahi Suleiman, Hameedah Ayomide Gbadamosi, Oluwadamilare Akingbade
Kaio Mota-Ribeiro, Maria P Curado, Betine P M Iser, Mohsen Naghavi, Deborah C Malta, Max M Oliveira